CHRNE is a transmembrane acetylcholine receptor (AChR) and its mutations lead to congenital myasthenic syndrome which is responsible for perturbation on calcium signaling and post-synaptic Ca2+ accumulation (Zayas et al., 2007; Shen et al., 2018). This evidence concerns the gene CHRNE and congenital myasthenic syndrome.